Warther Private Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,092
Closed -$233K 66
2025
Q1
$233K Buy
+2,092
New +$223K 0.08% 61
2024
Q4
Sell
-1,887
Closed -$217K 88
2024
Q3
$217K Hold
1,887
0.08% 84
2024
Q2
$201K Buy
+1,887
New +$189K 0.08% 82

Other funds holding NVS

Warther Private Wealth's NVS Position: Q2 2025 in Review

Warther Private Wealth sold out of Novartis (NVS) in Q2 2025, closing a stake of 2,092 shares — an estimated $233K sold.

Warther Private Wealth first reported a position in NVS in Q2 2024 and held it in 3 quarters. The position peaked at $233K in Q1 2025. 1,383 funds tracked by Wall St. Rank hold NVS as of Q2 2025.

  • Warther Private Wealth reported no remaining Novartis position as of Q2 2025 after selling out during the quarter.
  • Warther Private Wealth sold 2,092 Novartis shares in Q2 2025, an estimated $233K.
  • Warther Private Wealth first reported a position in Novartis in Q2 2024 and held it in 3 quarters.
  • Warther Private Wealth's Novartis position peaked at $233K in Q1 2025.
  • 1,383 funds tracked by Wall St. Rank held Novartis as of Q2 2025.

Based on Warther Private Wealth's 13F filing for Q2 2025, filed 30 Jul 2025.